Scienmag
NOVEMBER 17, 2020
Scientists have established a new method to image proteins that could lead to new discoveries in disease through biological tissue and cell analysis and the development of new biomaterials that can be used for the next generation of drug delivery systems and medical devices.
Drug Discovery World
APRIL 25, 2024
It will take place on 2 May at 3pm BST, 10am EDT, 4pm CEST and will be presented by Ron Morena, Manager in Analytical Bioassay at Tanvex Biopharma CDMO, along with and Dr Neha Mishra, Senior Scientist in the BioProduction R&D team, Revvity. Characterizing binding properties of complex biomolecules is a critical step.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Discovery World
APRIL 18, 2024
It will take place on 2 May at 3pm BST, 10am EDT, 4pm CEST and will be presented by Ron Morena, Manager in Analytical Bioassay at Tanvex Biopharma CDMO, along with and Dr Neha Mishra, Senior Scientist in the BioProduction R&D team, Revvity. Characterizing binding properties of complex biomolecules is a critical step.
Roots Analysis
MAY 21, 2024
LNPs comprise of a lipid bilayer that surrounds a hydrophobic core, which can be loaded with therapeutic agents ( such as drugs, genetic material and proteins ). The average size of LNPs typically ranges from 40 to 1,000 nanometers, which allows efficient cellular uptake and intracellular delivery.
pharmaphorum
JUNE 30, 2021
AdCOVID was able to stimulate antibodies that bound the SARS-CoV-2 spike protein and were able to neutralise the virus, but not in sufficient quantities and in too few patients.
Drug Discovery World
APRIL 3, 2023
As a business of scientists, we remain passionate about the exciting developments in the industry, from research to precision therapies, and insatiably curious about the new possibilities that can be achieved by overcoming the limits of standard research tools and methods. To what do you attribute your success?
Drug Discovery World
NOVEMBER 17, 2022
Its strategy is based on identifying, selecting, and nurturing high-quality European science and this model aims to bring together scientists from across Europe, combining tools and expertise from academia and industry. . This could have significant implications for our understanding of biology, in treating illness and in drug delivery.
Expert insights. Personalized for you.
67 
Let's personalize your content